KIT, which is a famous oncogene, is often mutated in advanced melanoma and contributes to malignancy progression and an unfavorable prognosis [28, 29], while highly expressed TNFSF14 in human melanoma cells and microvesicles may contribute to the mediation of T cell responses to cancer cells [30]. The gene discussed is TNFSF14; the disease is melanoma.